The future of antibody based drugs: Where are the opportunities?

""

This report will:  

  • Provide an overview of the monoclonal antibody (mAbs) industry: market value, key on the future of antibody-based drug players, opportunities and the future 
  • Explore what’s next for antibody-based drugs and where the opportunity is coming from 
  • Include an interview Bio-Rad’s John Cardone, who shares expertise on the future of antibody-based drug discovery  
  • Share significant future trends for the therapeutic antibody market 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free